Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function
NCT07079852Phase 2Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Aug 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial comparing placebo with psilocybin (2 arms). Primary endpoints: Memory accuracy from performance on a recognition memory test at 8 weeks and Neural correlates of memory as measured from fMRI at 8 weeks. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
psilocybin
Beyond the preview
Go deeper on NCT07079852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07079852.